Sign in to continue:

Thursday, April 23rd, 2026

West Bancorporation, Inc. Q1 2026 Financial Results: Earnings, Balance Sheet, and SEC Filing Highlights




West Bancorporation, Inc. Q1 2026 Earnings Report: In-Depth Investor Analysis

West Bancorporation, Inc. Reports Robust Q1 2026 Earnings: Key Insights for Investors

Summary of Key Financial Results

  • Net Income Surges: West Bancorporation, Inc. (Nasdaq: WTBA) delivered net income of \$10.6 million for the first quarter ended March 31, 2026, a significant increase from \$7.8 million in Q1 2025.
  • Earnings Per Share: Basic earnings per common share grew to \$0.62, compared to \$0.47 in the prior year. Diluted EPS reached \$0.61 versus \$0.46 previously.
  • Net Interest Income: The Company posted net interest income of \$24.4 million, up from \$20.9 million a year ago, reflecting strong core banking operations.
  • Improved Noninterest Income: Noninterest income increased to \$2.6 million (Q1 2025: \$2.2 million), highlighting stronger service charge revenues and other fee-based activities.
  • Loan Portfolio & Asset Quality: Loan interest and fee income remained stable at around \$41 million, with no credit loss expense recorded this quarter, indicating stable asset quality.
  • Balance Sheet Strength: As of March 31, 2026, total assets were approximately \$4.14 billion, and stockholders’ equity stood at \$270.7 million.
  • Shares Outstanding: 17,028,101 common shares were outstanding as of April 22, 2026.

Price-Sensitive Highlights for Shareholders

  • Solid Profitability Growth: The sharp rise in net income and earnings per share could positively impact the company’s share price, as it demonstrates efficient management and improved profitability.
  • Stable Asset Quality: No credit loss expense was recorded, which signals disciplined lending and healthy loan performance—an important factor supporting confidence in the company’s risk management.
  • Dividend and Capital Position: While the report does not explicitly state dividend declarations, the strong retained earnings and increase in equity suggest the company remains well-capitalized, which may support future dividend stability or increases.
  • Shareholder Structure Unchanged: The number of shares outstanding remained stable, with no indication of significant share issuances or buybacks in the quarter, minimizing dilution risk.
  • Regulatory Status: The company remains fully compliant with all SEC reporting obligations, is not a shell company, and is not considered an emerging growth company or smaller reporting company, providing investors with regulatory clarity.

Detailed Financial Snapshot

Metric Q1 2026 Q1 2025
Net Income \$10.6 million \$7.8 million
Net Interest Income \$24.4 million \$20.9 million
Noninterest Income \$2.6 million \$2.2 million
Basic EPS \$0.62 \$0.47
Diluted EPS \$0.61 \$0.46
Total Assets \$4.14 billion Not stated
Stockholders’ Equity \$270.7 million Not stated
Shares Outstanding 17,028,101 Not stated

Other Noteworthy Details

  • No Preferred Stock Issued: The company has no preferred shares issued or outstanding, reducing the risk of future dilution from preferred equity.
  • Strong Liquidity Position: Cash and cash equivalents at quarter-end were \$362 million, providing ample liquidity for operations and growth.
  • Credit Quality: The company recorded no provision for loan losses, reflecting sound underwriting standards and a healthy loan portfolio.
  • Expense Management: Efficiency is evident as noninterest expenses were well contained, supporting the bottom-line performance.

Conclusion

West Bancorporation, Inc.’s first quarter 2026 results demonstrate a robust financial performance, marked by higher profitability, prudent risk management, and a strong balance sheet. The absence of any negative surprises, combined with rising earnings and solid asset quality, could act as a catalyst for positive share price movement. Investors should pay attention to the company’s ability to maintain these trends, especially in the current interest rate environment.

Disclaimer

This article is provided for informational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a qualified financial advisor before making investment decisions. The author and publisher are not responsible for actions taken based on this information.




View WEST BANCORPORATION INC Historical chart here



TruGolf Holdings, Inc. 2025 10-K/A Report: Company Details, Nasdaq Listing, and Compliance Information

TruGolf Holdings, Inc. Files Amendment to Annual Report: Key...

Supernus Pharmaceuticals Acquires NV-5138 (SPN-820) Compound from Navitor Pharmaceuticals in Asset Purchase Agreement

Supernus Pharmaceuticals, Inc. Announces Entry into Asset Pu...

Vaxcyte, Inc. 8-K Filing Details, Sales Agreement with Leerink Partners, and Entity Information (2026)

Vaxcyte, Inc. Announces New \$500 Million At-the-Market Equi...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today